Norway currently reports an research & development by business enterprise, pharmaceutical industry in current ppp $ of 52.01 million, which represents an increase of 5.84 million (12.6%) from 2020.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Norway
No matching regions
Similar regions to Norway
Business R&D pharmaceutical in current PPP $
More indicators for Norway
Government R&D in security as % of government support
2.91%
+0.22%
(2021)
Higher-education-finacing R&D financed by general university in local currency
184,346.70M
+6,664.70M
(2021)
R&D financed by rest of the world in local currency
65,896.14M
+4,998.14M
(2021)
Government R&D financed by rest of the world in local currency
6,078.91M
+222.91M
(2021)
Business R&D financed by rest of the world in local currency
48,835.97M
+3,672.97M
(2021)
Non-profit R&D growth rate
-100%
-120.34%
(2022)
Norway Business R&D pharmaceutical in current PPP $ between 1987 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 52.01M | +5.84M |
| 2020 | 46.17M | +0.80M |
| 2019 | 45.37M | +0.64M |
| 2018 | 44.73M | +3.20M |
| 2017 | 41.53M | +6.07M |
| 2016 | 35.46M | +2.22M |
| 2015 | 33.24M | -3.56M |
| 2014 | 36.81M | -5.68M |
| 2013 | 42.48M | -0.87M |
| 2012 | 43.35M | -35.97M |
| 2011 | 79.33M | +25.53M |
| 2010 | 53.80M | +3.52M |
| 2009 | 50.27M | -5.81M |
| 2008 | 56.09M | +0.38M |
| 2007 | 55.71M | +2.85M |
| 2006 | 52.86M | +0.73M |
| 2005 | 52.13M | -4.69M |
| 2004 | 56.82M | +10.51M |
| 2003 | 46.31M | +3.86M |
| 2002 | 42.45M | -4.59M |
| 2001 | 47.03M | -10.10M |
| 2000 | 57.13M | -1.57M |
| 1999 | 58.70M | +11.31M |
| 1998 | 47.39M | +10.93M |
| 1997 | 36.46M | -0.98M |
| 1996 | 37.45M | -6.67M |
| 1995 | 44.12M | -4.22M |
| 1993 | 48.34M | +1.49M |
| 1992 | 46.86M | +3.88M |
| 1991 | 42.98M | +3.65M |
| 1990 | 39.33M | +4.65M |
| 1989 | 34.68M | +6.50M |
| 1988 | 28.18M | +8.18M |
| 1987 | 19.99M |